Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

1.

Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1.

Møller MN, Werther K, Nalla A, Stangerup SE, Thomsen J, Bøg-Hansen TC, Nielsen HJ, Cayé-Thomasen P.

Laryngoscope. 2010 Apr;120(4):657-62. doi: 10.1002/lary.20834.

PMID:
20205165
[PubMed - indexed for MEDLINE]
2.
3.

[Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].

Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.

Ai Zheng. 2004 Oct;23(10):1194-8. Chinese.

PMID:
15473934
[PubMed - indexed for MEDLINE]
4.

VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate.

Cayé-Thomasen P, Werther K, Nalla A, Bøg-Hansen TC, Nielsen HJ, Stangerup SE, Thomsen J.

Otol Neurotol. 2005 Jan;26(1):98-101.

PMID:
15699727
[PubMed - indexed for MEDLINE]
5.

Immunohistochemical demonstration of vascular endothelial growth factor in vestibular schwannomas correlates to tumor growth rate.

Cayé-Thomasen P, Baandrup L, Jacobsen GK, Thomsen J, Stangerup SE.

Laryngoscope. 2003 Dec;113(12):2129-34.

PMID:
14660915
[PubMed - indexed for MEDLINE]
6.

Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.

Ma DH, Chen JK, Kim WS, Hao YX, Wu HC, Tsai RJ, Hwang DG, Zhang F.

Ophthalmic Res. 2001 Nov-Dec;33(6):353-62.

PMID:
11721189
[PubMed - indexed for MEDLINE]
7.

[Correlation between matrix metalloproteinases-2 and tissue inhibitor of metalloproteinase-2 expression, metastatic potential and tumor angiogenesis in synovial sarcoma and its prognostic significance].

Sun BC, Sun Y, Zhao XL, Wang J, Wang X, Liu YX.

Zhonghua Bing Li Xue Za Zhi. 2006 Mar;35(3):155-8. Chinese.

PMID:
16630504
[PubMed - indexed for MEDLINE]
8.

Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.

Ozen O, Krebs B, Hemmerlein B, Pekrun A, Kretzschmar H, Herms J.

Clin Cancer Res. 2004 Jul 15;10(14):4746-53.

PMID:
15269148
[PubMed - indexed for MEDLINE]
Free Article
9.

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma.

Manenti L, Paganoni P, Floriani I, Landoni F, Torri V, Buda A, Taraboletti G, Labianca R, Belotti D, Giavazzi R.

Eur J Cancer. 2003 Sep;39(13):1948-56.

PMID:
12932675
[PubMed - indexed for MEDLINE]
10.

The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters.

Giannopoulos G, Pavlakis K, Parasi A, Kavatzas N, Tiniakos D, Karakosta A, Tzanakis N, Peros G.

Anticancer Res. 2008 May-Jun;28(3B):1875-81.

PMID:
18630474
[PubMed - indexed for MEDLINE]
Free Article
11.

Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.

Komorowski J, Pasieka Z, Jankiewicz-Wika J, Stepień H.

Thyroid. 2002 Aug;12(8):655-62.

PMID:
12225633
[PubMed - indexed for MEDLINE]
12.

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC.

BMC Cancer. 2009 Jan 14;9:20. doi: 10.1186/1471-2407-9-20.

PMID:
19144199
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.

Jobim FC, Xavier NL, Uchoa DM, Cruz DB, Saciloto M, Chemello N, Schwartsmann G.

Braz J Med Biol Res. 2009 Oct;42(10):979-87. Epub 2009 Sep 4.

PMID:
19787153
[PubMed - indexed for MEDLINE]
Free Article
14.

Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium.

Freitas S, Meduri G, Le Nestour E, Bausero P, Perrot-Applanat M.

Biol Reprod. 1999 Oct;61(4):1070-82.

PMID:
10491646
[PubMed - indexed for MEDLINE]
Free Article
15.

Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.

Sakata K, Shigemasa K, Nagai N, Ohama K.

Int J Oncol. 2000 Oct;17(4):673-81.

PMID:
10995877
[PubMed - indexed for MEDLINE]
16.

Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.

Collen A, Hanemaaijer R, Lupu F, Quax PH, van Lent N, Grimbergen J, Peters E, Koolwijk P, van Hinsbergh VW.

Blood. 2003 Mar 1;101(5):1810-7. Epub 2002 Sep 19.

PMID:
12393408
[PubMed - indexed for MEDLINE]
Free Article
17.

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.

Misugi F, Sumi T, Okamoto E, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.

Int J Mol Med. 2005 Oct;16(4):541-6.

PMID:
16142384
[PubMed - indexed for MEDLINE]
18.

[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].

Zhou CY, Yao JF, Chen XD.

Ai Zheng. 2002 Jul;21(7):735-9. Chinese.

PMID:
12479097
[PubMed - indexed for MEDLINE]
19.

[Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].

He DS, Chen MZ, Wang HJ, Ke CL, Yan C, Zheng H, Hong YS.

Ai Zheng. 2002 Oct;21(10):1124-8. Chinese.

PMID:
12508658
[PubMed - indexed for MEDLINE]
20.

Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.

Pesta M, Holubec L Jr, Topolcan O, Cerna M, Rupert K, Holubec LS, Treska V, Kormunda S, Elgrova L, Finek J, Cerny R.

Anticancer Res. 2005 Sep-Oct;25(5):3387-91.

PMID:
16101153
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk